Tenenbaum Fabian 4
4 · Bellerophon Therapeutics, Inc. · Filed Nov 23, 2018
Insider Transaction Report
Form 4
Tenenbaum Fabian
Chief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2018-11-20+1,487,500→ 3,676,197 totalExercise: $0.91Exp: 2028-11-20→ Common Stock (1,487,500 underlying)
Footnotes (1)
- [F1]This option was granted on November 20, 2018. This option vests in quarterly installments over a four-years period from the date of grant.